Browse by Phase
Phase 1 / Phase 2 Clinical Trials
Phase 1/2 combined trials evaluate both safety (Phase 1) and preliminary efficacy (Phase 2) in a single study protocol, often used to accelerate early development.
Total Trials
361
Recruiting Now
361
Top Conditions in Phase 1 / Phase 2
NCT04864054 Phase 1, Phase 2
Recruiting
T-Cell Therapy (ECT204) in Adults With Advanced HCC
Condition
Hepatocellular Carcinoma
Enrollment
20 pts
Location
United States, Taiwan
Sponsor
Eureka Therapeutics Inc.
NCT07229586 Phase 1, Phase 2
Recruiting
A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
Condition
Solid Tumor
Enrollment
100 pts
Location
China
Sponsor
Shanghai Hengrui Pharmaceutica
NCT06074783 Phase 1, Phase 2
Recruiting
A Study of Human Allogeneic Bone-marrow Derived Mesenchymal Stromal Cell Product...
Condition
Musculoskeletal Injury
Enrollment
30 pts
Location
The Bahamas
Sponsor
Cellcolabs Clinical LTD.
NCT06732856 Phase 1, Phase 2
Recruiting
A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and ...
Condition
Stomach Neoplasm
Enrollment
57 pts
Location
South Korea
Sponsor
Asan Medical Center
NCT06795022 Phase 1, Phase 2
Recruiting
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metast...
Condition
Hepatocellular Carcinoma
Enrollment
304 pts
Location
United States, China, Hong Kong
Sponsor
AstraZeneca
NCT03965234 Phase 1, Phase 2
Recruiting
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sar...
Condition
Metastatic Bone Sarcoma
Enrollment
99 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
NCT04870944 Phase 1, Phase 2
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS ...
Condition
Diffuse Midline Glioma, H3 K27-Altered
Enrollment
63 pts
Location
United States, Australia
Sponsor
Children's Oncology Group
NCT06139211 Phase 1, Phase 2
Recruiting
A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
186 pts
Location
China
Sponsor
Shanghai Junshi Bioscience Co.
NCT03298334 Phase 1, Phase 2
Recruiting
Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.
Condition
Cesarean Delivery Affecting Newborn
Enrollment
600 pts
Location
United States
Sponsor
National Institute of Allergy
NCT05675813 Phase 1, Phase 2
Recruiting
Genotype-guided Treatment in Newly Diagnosed PTCL
Condition
Peripheral T Cell Lymphoma
Enrollment
264 pts
Location
China
Sponsor
Ruijin Hospital
NCT03582124 Phase 1, Phase 2
Recruiting
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During...
Condition
Lung Carcinoma
Enrollment
30 pts
Location
United States
Sponsor
Stanford University
NCT07028073 Phase 1, Phase 2
Recruiting
A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia
Condition
Acute Myeloid Leukemia With T(8;21)(Q22;Q22)
Enrollment
78 pts
Location
China
Sponsor
The First Affiliated Hospital
NCT05518188 Phase 1, Phase 2
Recruiting
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimi...
Condition
Spasticity, Muscle
Enrollment
4 pts
Location
United States
Sponsor
Elpida Therapeutics SPC
NCT06963905 Phase 1, Phase 2
Recruiting
Saci Nivo Rela for TNBC
Condition
Metastatic Triple-negative Breast Cancer
Enrollment
60 pts
Location
United States
Sponsor
Yale University
NCT06214156 Phase 1, Phase 2
Recruiting
A Clinical Study of T3011 in Subjects With Advanced Melanoma
Condition
Advanced Melanoma
Enrollment
42 pts
Location
China
Sponsor
Shanghai Pharmaceuticals Holdi
NCT05359653 Phase 1, Phase 2
Recruiting
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumar...
Condition
Multiple Sclerosis (MS)
Enrollment
74 pts
Location
United States
Sponsor
University of California, San
NCT06735170 Phase 1, Phase 2
Recruiting
Tuberoplasty Versus Balloon Spacer
Condition
Rotator Cuff Tears
Enrollment
40 pts
Location
United States
Sponsor
University of Minnesota
NCT06530251 Phase 1, Phase 2
Recruiting
A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
Condition
Hepatocellular Carcinoma
Enrollment
280 pts
Location
China
Sponsor
Akeso
NCT04386967 Phase 1, Phase 2
Recruiting
OH2 Injection in Solid Tumors
Condition
Solid Tumor
Enrollment
30 pts
Location
China
Sponsor
Binhui Biopharmaceutical Co.,
NCT07269041 Phase 1, Phase 2
Recruiting
Immune Tolerance Induction After Liver Transplantation
Condition
Liver Transplantation
Enrollment
12 pts
Location
United States
Sponsor
University of California, Los
NCT06826612 Phase 1, Phase 2
Recruiting
A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's D...
Condition
Huntington Disease
Enrollment
53 pts
Location
United States
Sponsor
Hoffmann-La Roche
NCT06597695 Phase 1, Phase 2
Recruiting
A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With ...
Condition
Depression
Enrollment
10 pts
Location
United States
Sponsor
Juliana Zambrano, MD, MPH
NCT06389877 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With A...
Condition
Alpha 1-Antitrypsin Deficiency
Enrollment
106 pts
Location
United States, Australia, Ireland
Sponsor
Beam Therapeutics Inc.
NCT06292780 Phase 1, Phase 2
Recruiting
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or R...
Condition
Relapsed/Refractory Systemic Light Chain Amyloidosis
Enrollment
220 pts
Location
United States, South Korea, Spain
Sponsor
Regeneron Pharmaceuticals
NCT06118086 Phase 1, Phase 2
Recruiting
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid...
Condition
Adenoid Cystic Carcinoma
Enrollment
100 pts
Location
United States, France
Sponsor
Remix Therapeutics